1 of 1
Story summary
- Hisamitsu Pharmaceutical Co., led by Kazuhide Nakatomi of the founding family, announced a management buyout valued at approximately 390 billion yen to take the company private.
- Nakatomi will offer 6,082 yen per share, a 35% premium.
- The tender offer runs from January 7 to February 19.
- Hisamitsu plans to invest over 200 billion yen in expanding operations and research to enhance competitiveness in domestic and international markets.
